Neoadjuvant chemoradiotherapy plus PD-1 blockade for high or very high-risk locally advanced rectal cancer

被引：0
|
作者：
Liu, X. [1 ]
He, L. [2 ]
Tong, W. [2 ]
Li, S. [2 ]
Wang, Z. [1 ]
Gu, M. [1 ]
Li, Y. [1 ]
Liu, Z. [1 ]
Chang, P. [1 ]
Wang, Q. [2 ]
机构：
[1] First Hosp Jilin Univ, Dept Radiat Oncol & Therapy, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Gastrocolorectal Surg, Gen Surg Ctr, Changchun, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.annonc.2024.05.259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
252P
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [1] PD-1 inhibitor plus concurrent chemoradiotherapy for high-risk locally advanced cervical cancer
    Wang, Cong
    Liu, Lijun
    Li, Xia
    Lei, Jia
    Li, Yiqian
    Shen, Zhibo
    Shi, Huirong
    Cheng, Yan
    FUTURE ONCOLOGY, 2024, 20 (20) : 1415 - 1426
  • [2] Total neoadjuvant chemoradiation combined with neoadjuvant PD-1 blockade for patients with pMMR, high-risk, and locally advanced middle to low rectal cancer.
    Wu, Aiwen
    Li, Yingjie
    Ji, Dengbo
    Zhang, Li
    Zhang, Xiaoyan
    Cai, Yong
    Zhang, Yangzi
    Yao, Yunfeng
    Wang, Lin
    Leng, Jiahua
    Zhan, Tiancheng
    Sun, Ying-Shi
    Li, Zhongwu
    Cui, Xiaoli
    Luo, Haitao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer
    Li, Yingjie
    Pan, Chaohu
    Gao, Yuye
    Zhang, Li
    Ji, Dengbo
    Cui, Xiaoli
    Zhang, Xiaoyan
    Cai, Yong
    Zhang, Yangzi
    Yao, Yunfeng
    Wang, Lin
    Leng, Jiahua
    Zhan, Tiancheng
    Wu, Dongfang
    Gao, Zhibo
    Sun, Ying-Shi
    Li, Zhongwu
    Luo, Haitao
    Wu, Aiwen
    JAMA SURGERY, 2024, 159 (05) : 529 - 537
  • [4] Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients
    Wei, Jia
    Lu, Xiaofeng
    Liu, Qin
    Li, Lin
    Liu, Song
    Liu, Fangcen
    Fu, Yao
    Fan, Xiangshan
    Yang, Yang
    Qi, Chuang
    Yu, Yangyang
    Guan, Wenxian
    Liu, Baorui
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [5] PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancer
    Somasundaram, Ashwin
    Sanoff, Hanna K.
    CANCER CELL, 2024, 42 (09) : 1489 - 1491
  • [6] Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer
    Mi Mi
    Chenyang Ye
    Ying Yuan
    Signal Transduction and Targeted Therapy, 7
  • [7] Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial
    Yang, Yingchi
    Pang, Kai
    Lin, Guole
    Liu, Xinzhi
    Gao, Jiale
    Zhou, Jiaolin
    Xu, Lai
    Gao, Zhidong
    Wu, Yingchao
    Li, Ang
    Han, Jiagang
    Wu, Guoju
    Wang, Xin
    Li, Fei
    Ye, Yingjiang
    Zhang, Jie
    Chen, Guangyong
    Wang, Hao
    Kong, Yuanyuan
    Wu, Aiwen
    Xiao, Yi
    Yao, Hongwei
    Zhang, Zhongtao
    NATURE MEDICINE, 2025, 31 (02) : 449 - 456
  • [8] Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer:Propensity score study
    Xue-Qing Sheng
    Hong-Zhi Wang
    Shuai Li
    Yang-Zi Zhang
    Jian-Hao Geng
    Xiang-Gao Zhu
    Ji-Zhong Quan
    Yong-Heng Li
    Yong Cai
    Wei-Hu Wang
    World Journal of Gastrointestinal Oncology, 2022, 14 (09) : 1711 - 1726
  • [9] Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study
    Sheng, Xue-Qing
    Wang, Hong-Zhi
    Li, Shuai
    Zhang, Yang-Zi
    Geng, Jian-Hao
    Zhu, Xiang-Gao
    Quan, Ji-Zhong
    Li, Yong-Heng
    Cai, Yong
    Wang, Wei-Hu
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (09) : 1711 - 1726
  • [10] Induction chemotherapy followed by chemoradiotherapy and TME for high-risk locally advanced rectal cancer.
    Ding, P.
    Weiser, M. R.
    Hajj, C.
    Saltz, L.
    Segal, N. H.
    Goodman, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345